Log In
Print
BCIQ
Print
Print this Print this
 

Selincro, nalmefene

  Manage Alerts
Collapse Summary General Information
Company Biotie Therapies Corp.
DescriptionOpioid receptor antagonist
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat alcohol addiction; Treat pathological gambling; Treat smoking cessation
Regulatory Designation

Partner

H. Lundbeck A/S; Otsuka Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today